Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Schweizer

Showing results (161-170 of 267) with videos related to

Pageof 27
Sort By:
The Prostate|August 27, 2015
Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancerBenjamin L Maughan, Xian C Xhou, Daniel L Suzman, et al.
Journal of Bacteriology|July 1, 1996
Ferric uptake regulator (Fur) mutants of Pseudomonas aeruginosa demonstrate defective siderophore-mediated iron uptake, altered aerobic growth, and decreased superoxide dismutase and catalase activitiesD J Hassett, P A Sokol, M L Howell, et al.
European Journal of Clinical Nutrition|April 1, 1993
Structural features of resistant starch at the end of the human small intestineN Faisant, M Champ, P Colonna, et al.
Medical Oncology (Northwood, London, England)|June 15, 2016
Docetaxel-related toxicity in metastatic hormone-sensitive and metastatic castration-resistant prostate cancerMichael T Schweizer, Roman Gulati, Elahe A Mostaghel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2020
Multicenter Phase I Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand-binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate CancerChristos E Kyriakopoulos, Jens C Eickhoff, Anna C Ferrari, et al.
JCO Precision Oncology|July 14, 2022
<i>BRCA2</i> Alterations in Neuroendocrine/Small-Cell Carcinoma Prostate Cancer: A Case SeriesLynn Symonds, Erik Konnick, Funda Vakar-Lopez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2013
Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapyM T Schweizer, X C Zhou, H Wang, et al.
Transplantation|July 1, 1985
Evidence that cyclosporine-incubated platelets retain function and release cyclosporineR J Sharpe, R T Schweizer, R E Moore, et al.
Advances in Therapy|October 8, 2020
A Retrospective Observational Analysis of Overall Survival with Sipuleucel-T in Medicare Beneficiaries Treated for Advanced Prostate CancerRana R McKay, Jason M Hafron, Christine Ferro, et al.
Cancers|December 7, 2017
Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and QuestionsOsama S Mohammad, Michael D Nyquist, Michael T Schweizer, et al.
Pageof 27

Showing results (161-170 of 267) with videos related to

Sort By:
Pageof 27
The Prostate|August 27, 2015
Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancerBenjamin L Maughan, Xian C Xhou, Daniel L Suzman, et al.
Journal of Bacteriology|July 1, 1996
Ferric uptake regulator (Fur) mutants of Pseudomonas aeruginosa demonstrate defective siderophore-mediated iron uptake, altered aerobic growth, and decreased superoxide dismutase and catalase activitiesD J Hassett, P A Sokol, M L Howell, et al.
European Journal of Clinical Nutrition|April 1, 1993
Structural features of resistant starch at the end of the human small intestineN Faisant, M Champ, P Colonna, et al.
Medical Oncology (Northwood, London, England)|June 15, 2016
Docetaxel-related toxicity in metastatic hormone-sensitive and metastatic castration-resistant prostate cancerMichael T Schweizer, Roman Gulati, Elahe A Mostaghel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2020
Multicenter Phase I Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand-binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate CancerChristos E Kyriakopoulos, Jens C Eickhoff, Anna C Ferrari, et al.
JCO Precision Oncology|July 14, 2022
<i>BRCA2</i> Alterations in Neuroendocrine/Small-Cell Carcinoma Prostate Cancer: A Case SeriesLynn Symonds, Erik Konnick, Funda Vakar-Lopez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2013
Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapyM T Schweizer, X C Zhou, H Wang, et al.
Transplantation|July 1, 1985
Evidence that cyclosporine-incubated platelets retain function and release cyclosporineR J Sharpe, R T Schweizer, R E Moore, et al.
Advances in Therapy|October 8, 2020
A Retrospective Observational Analysis of Overall Survival with Sipuleucel-T in Medicare Beneficiaries Treated for Advanced Prostate CancerRana R McKay, Jason M Hafron, Christine Ferro, et al.
Cancers|December 7, 2017
Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and QuestionsOsama S Mohammad, Michael D Nyquist, Michael T Schweizer, et al.
Pageof 27